gene_symbol
CD38
hgnc_id
HGNC:1667
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Daratumumab binds CD38 on target cells and, via its Fc region, recruits immune effectors to kill by ADCC (NK cells), CDC (complement), and ADCP (macrophages); crosslinking can also directly induce apoptosis.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Type II transmembrane glycoprotein; ectoenzyme (ADP-ribosyl cyclase/cADPR hydrolase)
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06413498
disease_id_num_tar_ref
3588
drug_id_num_tar_ref
9741